These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 15866697)
21. Plasmapheresis as rescue therapy in accelerated acute humoral rejection. Abraham KA; Brown C; Conlon PJ; Donohoe J; Hickey DP; O'Neill D; Keogan MT; Dorman AM; Walshe J J Clin Apher; 2003; 18(3):103-10. PubMed ID: 14569599 [TBL] [Abstract][Full Text] [Related]
22. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation. Li X; Ishida H; Yamaguchi Y; Tanabe K Transpl Int; 2008 Dec; 21(12):1145-52. PubMed ID: 18803618 [TBL] [Abstract][Full Text] [Related]
23. Role of donor age and acute rejection episodes on long-term graft survival in cadaveric kidney transplantations. Emiroğlu R; Yagmurdur MC; Karakayali F; Haberal C; Ozcelik U; Colak T; Haberal M Transplant Proc; 2005 Sep; 37(7):2954-6. PubMed ID: 16213272 [TBL] [Abstract][Full Text] [Related]
24. [Multimodal treatment for acute antibody-mediated renal transplant rejection: successful rescue therapy with combined plasmapheresis, photopheresis and intravenous immunoglobulin]. Lai Q; Pretagostini R; Gozzer M; Cinti P; Meo D; Vita F; Bafti MS; Poli L; Novelli G; Rossi M; Girelli G; Berloco PB G Ital Nefrol; 2012; 29 Suppl 54():S31-5. PubMed ID: 22388827 [TBL] [Abstract][Full Text] [Related]
25. Clearance of C4d deposition after successful treatment of acute humoral rejection in follow-up biopsies: a report of three cases. Koller H; Steurer W; Mark W; Margreiter R; Lhotta K; Mayer G; Rosenkranz AR Transpl Int; 2004 May; 17(4):177-81. PubMed ID: 15114439 [TBL] [Abstract][Full Text] [Related]
26. Effect of plasmapheresis for acute humoral rejection after heart transplantation. Wang SS; Chou NK; Ko WJ; Chi NH; Hung SC; Hsu RB; Yu HY; Chen YS; Chu SH; Tsao CI; Shun CT Transplant Proc; 2006 Dec; 38(10):3692-4. PubMed ID: 17175369 [TBL] [Abstract][Full Text] [Related]
27. Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: Analysis of UNOS Database. Simpson N; Cho YW; Cicciarelli JC; Selby RR; Fong TL Transplantation; 2006 Nov; 82(10):1298-303. PubMed ID: 17130778 [TBL] [Abstract][Full Text] [Related]
28. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Montgomery RA; Zachary AA; Racusen LC; Leffell MS; King KE; Burdick J; Maley WR; Ratner LE Transplantation; 2000 Sep; 70(6):887-95. PubMed ID: 11014642 [TBL] [Abstract][Full Text] [Related]
29. Bortezomib is effective to treat acute humoral rejection after liver transplantation. Lee CF; Eldeen FZ; Chan KM; Wu TH; Soong RS; Wu TJ; Chou HS; Lee WC Transplant Proc; 2012 Mar; 44(2):529-31. PubMed ID: 22410063 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens. Tanabe K; Ishida H; Shimizu T; Omoto K; Shirakawa H; Tokumoto T Contrib Nephrol; 2009; 162():61-74. PubMed ID: 19001814 [TBL] [Abstract][Full Text] [Related]
31. Hepatitis C, acute humoral rejection, and renal allograft survival. Forman JP; Tolkoff-Rubin N; Pascual M; Lin J J Am Soc Nephrol; 2004 Dec; 15(12):3249-55. PubMed ID: 15579529 [TBL] [Abstract][Full Text] [Related]
32. Management of the sensitized cardiac recipient: the use of plasmapheresis and intravenous immunoglobulin. Leech SH; Lopez-Cepero M; LeFor WM; DiChiara L; Weston M; Furukawa S; Macha M; Singhal A; Wald JW; Nikolaidis LA; McClurken JB; Bove AA Clin Transplant; 2006; 20(4):476-84. PubMed ID: 16842525 [TBL] [Abstract][Full Text] [Related]